Verition Fund Management
IMMU

Verition Fund Management’s Immunomedics Inc IMMU Stock Holding History

Verition Fund Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-267,697
Closed -$22.8M – 1541
2020
Q3 		$22.8M Buy
+267,697
New +$13.5M 0.45% 37

Verition Fund Management's IMMU Position: Q4 2020 in Review

Verition Fund Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 267,697 shares — an estimated $22.8M sold.

Verition Fund Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $22.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Verition Fund Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Verition Fund Management sold 267,697 Immunomedics Inc shares in Q4 2020, an estimated $22.8M.
  • Verition Fund Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Verition Fund Management's Immunomedics Inc position peaked at $22.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Verition Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.